Pfizer Service Company BV

Poland

All drugs from this manufacturer

  • ADRIBLASTINA PFS

    The medicinal product is used in the treatment of many types of cancer, including leukemias (acute and chronic), lymphomas, multiple myeloma, sarcomas, breast cancer, ovarian cancer, endometrial cancer, lung cancer, stomach cancer, bladder cancer, prostate cancer, liver cancer, thyroid cancer, as well as head and neck cancers.

    Dosage form: solution for injection

    Active substance Dosage
    doxorubicin hydrochloride 2 mg

    ATC: L01DB01

  • The medicine is used to treat aplastic anemia. It helps support the bone marrow in regenerating red blood cells, white blood cells, and platelets, which may also help avoid the need for blood transfusions.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    equine immunoglobulin against human t lymphocytes (eatg) 50 mg/ml

    ATC: L04AA03

  • The medicinal product is used in the treatment of patients with advanced colorectal cancer (colon and rectum) in various treatment regimens, depending on the stage of the disease and previous use of other therapies.

    Dosage form: solution for intravenous infusion, concentrate

    Active substance Dosage
    irinotecan hydrochloride 40 mg/2 ml

    ATC: L01CE02

  • The medicine is used in the treatment of advanced ovarian cancer and small cell lung cancer.

    Dosage form: solution for injection

    Active substance Dosage
    carboplatin 10 mg

    ATC: L01XA02

  • The medicinal product is used to treat acute myeloid leukaemia in adults and children, as well as to treat acute lymphoblastic leukaemia and chronic myeloid leukaemia. It may also be used to treat leukaemia with central nervous system involvement.

    Dosage form: solution for injection for infusion

    Active substance Dosage
    cytarabine 20 mg/ml

    ATC: L01BC01

  • The medicine is used for the treatment of acute myeloid leukemia in adults and children, acute lymphoblastic leukemia, and chronic myeloid leukemia. It may be used alone or in combination with other anticancer drugs.

    Dosage form: solution for injection for infusion

    Active substance Dosage
    cytarabine 100 mg/ml

    ATC: L01BC01

  • The medicinal product is used in the treatment of various types of cancer, including breast cancer, bladder cancer, stomach cancer, lung cancer, ovarian cancer, pancreatic cancer, colon and rectal cancer, lymphomas, leukemias, multiple myeloma, and soft tissue sarcomas.

    Dosage form: solution for injection and infusion

    Active substance Dosage
    epirubicin hydrochloride 50 mg

    ATC: L01DB03

  • The medicine is used to treat severe bacterial infections in adults and children over 3 months of age. It may be used for pneumonia, bronchopneumonia (in cystic fibrosis), complicated urinary tract infections, abdominal infections, skin and soft tissue infections, as well as intrapartum and postpartum infections and bacterial meningitis.

    Dosage form: powder for preparation of solution for injection or infusion

    Active substance Dosage
    meropenem 570 mg

    ATC: J01DH02

  • The medicinal product is used to treat adults and children (over 3 months of age) for, among other things, pneumonia, bronchopulmonary infections in cystic fibrosis, complicated urinary tract infections, abdominal infections, skin and soft tissue infections, as well as intrapartum and postpartum infections, and acute bacterial meningitis. It may also be used to treat bloodstream infections and in febrile patients with neutropenia.

    Dosage form: powder for preparation of solution for injection or infusion

    Active substance Dosage
    meropenem 1140 mg

    ATC: J01DH02

  • The medicine is used in adults and children for the treatment of various types of acute leukemia (non-lymphoblastic and lymphoblastic).

    Dosage form: solution for injection

    Active substance Dosage
    idarubicin hydrochloride 1 mg/ml

    ATC: L01DB06